Skip to content

Observation of therapeutic effect of Yang-supporting moxibustion in digital bladder management mode on patients with renal Yang decay type neurogenic bladder

Observation of therapeutic effect of Yang-supporting moxibustion in digital bladder management mode on patients with renal Yang decay type neurogenic bladder

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075471
Enrollment
Unknown
Registered
2023-09-06
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurogenic bladder

Interventions

Intervention group:On the basis of the control group, administer Fuyang Du moxibustion
Control group:Digital bladder management mode Full bladder management

Sponsors

Affiliated Hospital of Nanjing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Meet the above diagnostic standards of traditional Chinese and Western medicine; (2) Patients with stable vital signs and stable condition; (3) patients with infection without serious complications; (4) Residual urine volume >lOOml and bladder volume increased; (5) Age range from 18 to 60 years; (6) Able to actively cooperate with treatment and willing to sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with severe speech and cognitive impairment, combined with serious heart and lung diseases; (2) previous urethral injury, poor urination access; (3) The presence of severe urinary tract infection; (4) Those who have undergone urinary tract diversion surgery and are fitted with urethral stents or prostheses; (5) There is a bleeding tendency, skin ulceration, scar growth should not be applied moxibustion; (6) Allergic to ginger juice and smoke; (7) Daily intake of a large amount of liquid (diet, infusion) and can not control liquid intake;

Design outcomes

Primary

MeasureTime frame
Bladder function;Urination frequency;Number of urine leaks within 24 hours;Safe bladder capacity;Maximum bladder pressure;

Secondary

MeasureTime frame
Imaging index;Quality of life;

Countries

China

Contacts

Public ContactFanyan Meng

Affiliated Hospital of Nanjing University of Chinese Medicine

mfy565@126.com+86 136 7510 2616

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026